In humans, TET1 and TET2 have been previously shown to be concomitantly downregulated in B cell acute lymphoblastic leukemia and to have overlapping functions in B cell development and leukemogenesis [55]. This evidence concerns the gene TET1 and B-cell acute lymphoblastic leukemia.